Health Condition 1: 8- Other Procedures
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Adults aged between 18-65 years 2.Patients posted for elective laparoscopic 3.American society of anaesthesiologists (ASA) physical status I or II 4.Body Mass Index 18.5-30 kg/m2 5.Non pregnant, Non lactating females 6.Patients who provided written informed consent
Exclusion criteria
Exclusion criteria: Hypersensitivity to nitroglycerine Severe Anaemia History of significant cardiovascular disorders -ischemic heart disease, uncontrolled hypertension, arrhythmias, heart failure Patients on medications which interact with nitroglycerine - sildenafil, nitrates Unable or unwilling to comply with study protocol Patients with ASA greater than 2
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the efficacy of intranasal nitroglycerine spray versus intravenous nitroglycerine in attenuating the hemodynamic response (changes in blood pressure and heart rate) to pneumoperitoneum during laparoscopic surgery.Timepoint: Blood pressure, peripheral capillary oxygen saturation and heart rate measured at 2 mins before and 2, 4, 6, 8, 10, 15, 30, 45 minutes, and 1 hour after pneumoperitoneum initiation. | — |
Secondary
| Measure | Time frame |
|---|---|
| To see for adverse effects associated with intranasal nitroglycerine & intravenous nitroglycerineTimepoint: Blood pressure, peripheral capillary oxygen saturation & heart rate measured at 2 mins before & 2, 4, 6, 8, 10, 15, 30, 45 minutes, & 1 hour after pneumoperitoneum initiation. | — |
Countries
India
Contacts
IMS and SUM Hospital